Autolus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.About AUTL
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells.
CEOChristian Martin Itin
CEOChristian Martin Itin
Employees752
Employees752
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2018
Founded2018
Employees752
Employees752
AUTL Key Statistics
Market cap427.16M
Market cap427.16M
Price-Earnings ratio-1.49
Price-Earnings ratio-1.49
Dividend yield—
Dividend yield—
Average volume1.50M
Average volume1.50M
High today$1.69
High today$1.69
Low today$1.59
Low today$1.59
Open price$1.61
Open price$1.61
Volume2.14M
Volume2.14M
52 Week high$2.70
52 Week high$2.70
52 Week low$1.15
52 Week low$1.15
AUTL News
TipRanks 4d
Autolus Therapeutics: Strategic Positioning and Leadership Drive Confident Buy RatingAutolus Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Gil Blum from Needham maintained a Buy rating on the...
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.